Table 1 The relationship between clinicopathological characteristics and mucinous adenocarcinoma in stage I colorectal cancer
From: Survival after curative resection for stage I colorectal mucinous adenocarcinoma
| Variable | MAC (n = 58) | Non-MAC (n = 472) | p value |
|---|---|---|---|
| Sex | |||
| Male | 34 (58.6%) | 255 (54.0%) | 0.508 |
| Female | 24 (41.4%) | 217 (46.0%) | |
| Age | |||
| ≤ 65 | 40 (69.0%) | 291 (61.7%) | 0.278 |
| > 65 | 18 (31.0%) | 181 (38.3%) | |
| Preoperative CEA | |||
| ≤ 5 ng/dL | 53 (91.4%) | 413 (87.5%) | 0.393 |
| > 5 ng/dL | 5 (8.6%) | 59 (12.5%) | |
| T classification | |||
| 1 | 8 (13.8%) | 162 (34.3%) | 0.002* |
| 2 | 50 (86.2%) | 310 (65.7%) | |
| Location | |||
| Colon | 24 (41.4%) | 136 (28.8%) | 0.049* |
| Rectal | 34 (58.6%) | 336 (71.2%) | |
| Size | |||
| < 3 cm | 28 (48.3%) | 281 (59.5%) | 0.101 |
| ≥ 3 cm | 30 (51.7%) | 191 (40.5%) | |
| LVI | |||
| (−) | 54 (93.1%) | 457 (96.8%) | 0.151 |
| (+) | 4 (6.9%) | 15 (3.2%) | |
| Less than 12 lymph nodes | |||
| Yes | 10 (17.2%) | 87 (18.4%) | 0.825 |
| No | 48 (82.8%) | 385 (81.6%) | |
| dMMR | |||
| Yes | 7 (12.1%) | 14 (3.0%) | 0.001* |
| No | 51 (87.9%) | 458 (97.0%) |